Q32 Bio Inc. Common Stock (QTTB) is a publicly traded Healthcare sector company. As of October 12, 2026, QTTB trades at $8.68 with a market cap of $248.28M and a P/E ratio of 2.58. QTTB moved +4.08% today. Year to date, QTTB is +151.21%; over the trailing twelve months it is +157.41%. Its 52-week range spans $1.35 to $23.57. Analyst consensus is strong buy with an average price target of $38.86. Rallies surfaces QTTB's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
7 analysts cover QTTB: 0 strong buy, 7 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $38.86.
| Metric | Value |
|---|---|
| Price | $8.68 |
| Market Cap | $248.28M |
| P/E Ratio | 2.58 |
| EPS | $3.13 |
| Dividend Yield | 0.00% |
| 52-Week High | $23.57 |
| 52-Week Low | $1.35 |
| Volume | 13.46K |
| Avg Volume | 0 |
| Revenue (TTM) | $53.95M |
| Net Income | $33.79M |
| Gross Margin | 0.00% |
7 analysts cover QTTB: 0 strong buy, 7 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $38.86.